The cost of informal caregiving for Americans with heart disease and stroke is projected to more than double over the next two decades, increasing from $61 billion in 2015 to $128 billion by 2035, according to a policy statement published April 9 in Circulation.

Santa Clara, Calif. — April 5, 2018 — Cardiva Medical®, an innovator in the field of vascular closure, today announced the company has received approval from the U.S. Food and Drug Administration (FDA) for an expanded indication of the VASCADE® Vascular Closure System. Already approved for use in arterial closure, VASCADE is now FDA approved for use in 5-7F femoral venous closures as well.

A new technique for conducting cardiac MRI can be completed within 90 seconds, allows patients to breathe during testing and could ultimately improve diagnostic accuracy and reliability.

Speedy follow-up with patients after heart failure hospitalizations doesn’t boost medication adherence long-term, researchers reported April 1 in the Journal of the American Heart Association.

DUBLIN — April 9, 2018 — Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval to begin an investigational device exemption (IDE) pivotal trial to evaluate the Symplicity Spyral(TM) renal denervation system in patients with high blood pressure (hypertension).

People are more likely to prefer a daily cup of tea or a pill over exercise as a treatment options for high blood pressure, according to findings of a survey presented April 7 at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions 2018 in Arlington, Virginia.

Depression, whether it's diagnosed or not, can have several negative effects on the health of cardiovascular disease (CVD) patients, according to new research presented April 7 at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions 2018 in Arlington, Virginia.

ZIP codes may be related to the prevalence of obesity, according to new research from the University of Arkansas, published April 4 in Obesity Research & Clinical Practice.

Out-of-pocket expenses for the treatment of chronic heart disease lead to significant financial burdens for low-income families, even for those with health insurance, according to preliminary research presented April 6 at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions 2018 in Arlington, Virginia.

Victor Gurewich, MD, has spent more than two decades trying to spread the word about what he sees as an effective, lifesaving treatment approach to heart attack and stroke. At 88 years old, the cardiologist is hoping to breakthrough soon—and a new clinical trial in Europe could help.